← all works
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes
Why is this work in the frame?
A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.
Canadian affiliationAn author listed a Canadian institution. This is the only route the usual frame has.
Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.
The three-model screen
all 1,000 screened works →All three models called this out of scope.
stratum: aff_core · design weight: 5595.24 (the sample is stratified; any rate computed without the weight is wrong)
Claude Opus 4.8OUT
genre: empirical
about Canada: no
confidence: high
Encapsulation of cisplatin into thermosensitive liposomes; pharmaceutics.
GPT-5.6 (high)OUT
genre: empirical
about Canada: no
confidence: high
This pharmaceutical study develops a liposome drug-delivery method and does not study research itself.
Grok 4.5OUT
genre: empirical
about Canada: no
confidence: medium
Pharmaceutics methods for encapsulating cisplatin in thermosensitive liposomes; drug-delivery science.
Abstract
No abstract. This is not a gap in this database — OpenAlex has none either. 23.3% of the frame is in this state, and the screen finds HALF as much metaresearch here, so the absence is a measured bias rather than a missing field.
The record
- Venue
- International Journal of Pharmaceutics
- Topic
- Nanoparticle-Based Drug Delivery
- Field
- Materials Science
- Canadian institutions
- BC Cancer AgencyUniversity of British Columbia
- Funders
- Canadian Institutes of Health ResearchUniversity of British ColumbiaBC Cancer AgencyLotte and John Hecht Memorial Foundation
- Keywords
- LiposomeCisplatinPharmacokineticsChemistryHyperthermiaPharmacologyPhospholipidDrugDrug carrierBiophysicsMembraneChemotherapyMedicineBiochemistryInternal medicine
- Has abstract in OpenAlex
- no